150 related articles for article (PubMed ID: 26204499)
1. Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice.
Li G; Chen C; Laing SD; Ballard C; Biju KC; Reddick RL; Clark RA; Li S
Gene Ther; 2016 Jan; 23(1):78-85. PubMed ID: 26204499
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
[TBL] [Abstract][Full Text] [Related]
5. BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice.
Singla DK; Singla R; Wang J
PLoS One; 2016; 11(1):e0147897. PubMed ID: 26824441
[TBL] [Abstract][Full Text] [Related]
6. PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis.
Barish GD; Atkins AR; Downes M; Olson P; Chong LW; Nelson M; Zou Y; Hwang H; Kang H; Curtiss L; Evans RM; Lee CH
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4271-6. PubMed ID: 18337509
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-17-5p reduces the inflammation and lipid accumulation, and up-regulates ATP-binding cassette transporterA1 in atherosclerosis.
Tan L; Liu L; Jiang Z; Hao X
J Pharmacol Sci; 2019 Apr; 139(4):280-288. PubMed ID: 30850242
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages.
Yang S; Ye ZM; Chen S; Luo XY; Chen SL; Mao L; Li Y; Jin H; Yu C; Xiang FX; Xie MX; Chang J; Xia YP; Hu B
J Mol Cell Cardiol; 2018 Oct; 123():139-149. PubMed ID: 30227118
[TBL] [Abstract][Full Text] [Related]
10. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
[TBL] [Abstract][Full Text] [Related]
11. Metabonomic Changes Associated with Atherosclerosis Progression for LDLR(-/-) Mice.
Li D; Zhang L; Dong F; Liu Y; Li N; Li H; Lei H; Hao F; Wang Y; Zhu Y; Tang H
J Proteome Res; 2015 May; 14(5):2237-54. PubMed ID: 25784267
[TBL] [Abstract][Full Text] [Related]
12. Leptin decreases circulating inflammatory IL-6 and MCP-1 in mice.
Hoffmann A; Ebert T; Klöting N; Kolb M; Gericke M; Jeromin F; Jessnitzer B; Lössner U; Burkhardt R; Stumvoll M; Fasshauer M; Kralisch S
Biofactors; 2019 Jan; 45(1):43-48. PubMed ID: 30496627
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta.
Lee CH; Chawla A; Urbiztondo N; Liao D; Boisvert WA; Evans RM; Curtiss LK
Science; 2003 Oct; 302(5644):453-7. PubMed ID: 12970571
[TBL] [Abstract][Full Text] [Related]
14. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.
Wezel A; van der Velden D; Maassen JM; Lagraauw HM; de Vries MR; Karper JC; Kuiper J; Bot I; Quax PH
Atherosclerosis; 2015 Jan; 238(1):132-9. PubMed ID: 25484103
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
[TBL] [Abstract][Full Text] [Related]
16. Chitinase-3-like protein 1 ameliorates atherosclerotic responses via PPARδ-mediated suppression of inflammation and ER stress.
Jung TW; Park HS; Choi GH; Kim D; Jeong JH; Lee T
J Cell Biochem; 2018 Aug; 119(8):6795-6805. PubMed ID: 29737637
[TBL] [Abstract][Full Text] [Related]
17. The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice.
Graham TL; Mookherjee C; Suckling KE; Palmer CN; Patel L
Atherosclerosis; 2005 Jul; 181(1):29-37. PubMed ID: 15939051
[TBL] [Abstract][Full Text] [Related]
18. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
19. Curcuma oil attenuates accelerated atherosclerosis and macrophage foam-cell formation by modulating genes involved in plaque stability, lipid homeostasis and inflammation.
Singh V; Rana M; Jain M; Singh N; Naqvi A; Malasoni R; Dwivedi AK; Dikshit M; Barthwal MK
Br J Nutr; 2015 Jan; 113(1):100-13. PubMed ID: 25391643
[TBL] [Abstract][Full Text] [Related]
20. The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis.
Wei Y; Nazari-Jahantigh M; Chan L; Zhu M; Heyll K; Corbalán-Campos J; Hartmann P; Thiemann A; Weber C; Schober A
Circulation; 2013 Apr; 127(15):1609-19. PubMed ID: 23513069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
